Literature DB >> 9712523

Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development.

X Li1, S G Gray, F Flam, T Pietsch, T J Ekström.   

Abstract

We have previously shown that the four promoters of the IGF2 gene are under a tight but dynamic control during human liver development, whereby P3 and P1 are reciprocally active before and after birth respectively while the P2 and P4 promoters are constitutively active at a relatively lower level. In this study, we investigated the methylation status of the promoters P1 and P3 of IGF2 and the promoter region of the H19 gene in developing human livers ranging from fetal to late adult. A region of about 300 bp immediately upstream of the IGF2 exon 5 was found to be subjected to a developmental-specific methylation and this may correlate to the P3 promoter activity. The P1 domain of IGF2 was also found to be methylated in a developmentally-specific pattern. The promoter region of the H19 gene displayed different methylation patterns in different development stages showing decreased general methylation with increase of age. Therefore, regional- and developmental-specific DNA methylation is displayed in the promoter regions of the IGF2 and H19 genes. This may be an important factor involved in gene regulation in the developing human liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712523

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  10 in total

Review 1.  Post-natal imprinting: evidence from marsupials.

Authors:  J M Stringer; A J Pask; G Shaw; M B Renfree
Journal:  Heredity (Edinb)       Date:  2014-03-05       Impact factor: 3.821

2.  Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.

Authors:  Neha Goyal; Shweta Tiwary; Devesh Kesharwani; Malabika Datta
Journal:  J Mol Med (Berl)       Date:  2018-11-21       Impact factor: 4.599

3.  Altered microRNA Expression Patterns in Hepatoblastoma Patients.

Authors:  Armando Magrelli; Gianluca Azzalin; Marco Salvatore; Mara Viganotti; Fabrizio Tosto; Teresa Colombo; Rita Devito; Alessandra Di Masi; Antonio Antoccia; Stefano Lorenzetti; Francesca Maranghi; Alberto Mantovani; Caterina Tanzarella; Giuseppe Macino; Domenica Taruscio
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

4.  IGF-II promoter methylation and ovarian cancer prognosis.

Authors:  A C Beeghly; D Katsaros; A L Wiley; I A Rigault de la Longrais; A T Prescott; H Chen; M Puopolo; T J Rutherford; H Yu
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-14       Impact factor: 4.553

5.  Altered expression of members of the IGF-axis in hepatoblastomas.

Authors:  S G Gray; T Eriksson; C Ekström; S Holm; D von Schweinitz; P Kogner; B Sandstedt; T Pietsch; T J Ekström
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

6.  H19 and IGF-2 allele-specific expression in hepatoblastoma.

Authors:  J A Ross; G A Radloff; S M Davies
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

7.  Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.

Authors:  Stefan Küffer; Tobias Gutting; Djeda Belharazem; Christian Sauer; Maurice S Michel; Alexander Marx; Lutz Trojan; Philipp Ströbel
Journal:  Mol Oncol       Date:  2018-01-04       Impact factor: 6.603

Review 8.  Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases.

Authors:  Chad Pope; Shashank Mishra; Joshua Russell; Qingqing Zhou; Xiao-Bo Zhong
Journal:  Diseases       Date:  2017-03-08

9.  Promoter-specific expression and imprint status of marsupial IGF2.

Authors:  Jessica M Stringer; Shunsuke Suzuki; Andrew J Pask; Geoff Shaw; Marilyn B Renfree
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.

Authors:  S Honda; Y Arai; M Haruta; F Sasaki; M Ohira; H Yamaoka; H Horie; A Nakagawara; E Hiyama; S Todo; Y Kaneko
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.